FDA's Vaccine Chief Disregards Recommendations, Restricts COVID Shots

Strategic Insights -

The Food and Drug Administration's vaccine chief, Dr. Vinay Prasad, has personally intervened to place restrictions on COVID-19 vaccines from manufacturers Novavax and Moderna, disregarding recommendations from government scientists. This is according to federal documents released Wednesday. The new memos show Prasad decided to limit the shots to those who face special risks from the virus, such as seniors or children and adults with underlying medical issues. This decision was made despite the conclusion by the FDA staff that the benefit of the vaccines outweighed the risk of possible side effects, which are rare. Prasad explained that the COVID vaccine benefits must be reconsidered in light of falling rates of death and hospitalization and the possibility for vaccine side effects.

Key Takeaways:

  • Dr. Vinay Prasad, the FDA's vaccine chief, has personally intervened to restrict COVID-19 vaccines from Novavax and Moderna.
  • The restrictions were placed on the vaccines despite the conclusion by the FDA staff that the benefit of the vaccines outweighed the risk of possible side effects.
  • Prasad decided to limit the shots to those who face special risks from the virus, such as seniors or children and adults with underlying medical issues.
  • The risk-benefit assessment for the Novavax vaccine was deemed favorable by the review team, which pointed to data from a study in 30,000 adults.
  • The FDA staff reached a similar conclusion for the Moderna vaccine, deeming it similar in safety and effectiveness to the company's original shot.
  • Last week, the FDA finalized new warning labeling about the risk of myocarditis, a rare form of heart inflammation, on shots from Moderna and Pfizer.
  • Dr. Prasad has raised concerns about the risk of myocarditis and has ordered Moderna to conduct further studies as a condition for the approving its updated shot.

Statistics:

  • COVID-19 has resulted in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall.
  • Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months.
  • Novavax's vaccine is the only protein-based coronavirus vaccine available in the U.S.
  • Moderna's vaccine is an updated, lower-dose version of its existing mRNA-based vaccine.

Sources:

  • WASHINGTON (AP) — The working under Health Secretary recently of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday. (Source: The Associated Press)
  • An academic researcher, Prasad came to prominence during the pandemic for criticizing public health measures, including the FDA's approval of COVID boosters for healthy adults and children. (Source: The Associated Press)
  • The review team for the Novavax vaccine pointed to data from a study in 30,000 adults, concluding that “the risk-benefit assessment for this vaccine technology remains favorable.” (Source: The Associated Press)
  • Last week, the FDA finalized new warning labeling about the risk of myocarditis, a rare form of heart inflammation, on shots from Moderna and Pfizer, the other maker of an mRNA-based shot for COVID. (Source: The Associated Press)
  • The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. (Source: The Associated Press)